| ROSSEL, R., M. POLTORATSKIY, M. HOCHAMIR, K.K. LAKTINOV, R. RAMLAU, M. ALONSO, S. GARCIA, Jana SKŘIČKOVÁ, P.L. PIOVANO, S. RIZZATO, P. BIDOLI, D. KOWALSKI, L. CLEMENTI, A. CSECH a F. DE MARINIS. A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis. Online. In European Society for Medical Oncology - ESMO Asia Congress 2019. 2019, [citováno 2024-04-24] |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1590497,
author = {Rossel, R. and Poltoratskiy, M. and Hochamir, M. and Laktinov, K.K. and Ramlau, R. and Alonso, M. and Garcia, S. and Skřičková, Jana and Piovano, P.L. and Rizzato, S. and Bidoli, P. and Kowalski, D. and Clementi, L. and Csech, A. and De Marinis, F.},
booktitle = {European Society for Medical Oncology - ESMO Asia Congress 2019},
title = {A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis},
year = {2019}
}
TY - CONF
ID - 1590497
AU - Rossel, R. - Poltoratskiy, M. - Hochamir, M. - Laktinov, K.K. - Ramlau, R. - Alonso, M. - Garcia, S. - Skřičková, Jana - Piovano, P.L. - Rizzato, S. - Bidoli, P. - Kowalski, D. - Clementi, L. - Csech, A. - De Marinis, F.
PY - 2019
TI - A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis
ER -
ROSSEL, R., M. POLTORATSKIY, M. HOCHAMIR, K.K. LAKTINOV, R. RAMLAU, M. ALONSO, S. GARCIA, Jana SKŘIČKOVÁ, P.L. PIOVANO, S. RIZZATO, P. BIDOLI, D. KOWALSKI, L. CLEMENTI, A. CSECH a F. DE MARINIS. A phase lllb, open.label study of afatinib in EGFR TKI-naive patients with EGFR mutation-positive NSCLC: A biomarker analysis. Online. In \textit{European Society for Medical Oncology - ESMO Asia Congress 2019}. 2019, [citováno 2024-04-24]
|
